pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Boundless Bio is a biotechnology company committed to interrogating a previously unexplored dimension in cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

LOCATION

  • La Jolla, CA, USA

    • THERAPEUTIC AREAS

  • Oncology

    • WEBSITE

    https://boundlessbio.com

    CAREER WEBSITE

    https://boundlessbio.com/join-us

    SOCIAL MEDIA

    INVESTORS

    alexandria-venture-investments arch-venture-partners boxer-capital city-hill-ventures gt-healthcare-capital-partners vertex-ventures

    PRESS RELEASES


    Sep 19, 2023

    Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate VERZENIO (abemaciclib) in Combination with BBI-355 in Patients with CDK4 or CDK6 Amplified Solid Tumors


    Jul 31, 2023

    Boundless Bio Appoints Jami Rubin as Chief Financial Officer


    Jun 1, 2023

    Boundless Bio to Present at the 2023 Jefferies Healthcare Conference


    Jun 1, 2023

    Page Not Found


    Jun 1, 2023

    Boundless Bio to Present at the 2023 Jefferies Healthcare Conference


    For More Press Releases
    Google Analytics Alternative